Stockscreener 앱 받기
25.68
1.87%
-0.49
시간 외 거래:
25.68
전일 마감가:
$26.17
열려 있는:
$26.12
하루 거래량:
987.65K
Relative Volume:
0.63
시가총액:
$1.45B
수익:
$308.05M
순이익/손실:
$-95.57M
주가수익비율:
-14.93
EPS:
-1.72
순현금흐름:
$-58.34M
1주 성능:
-1.68%
1개월 성능:
-4.04%
6개월 성능:
-31.32%
1년 성능:
-55.57%
1일 변동 폭
$24.79
$26.45
1주일 범위
$24.79
$28.68
52주 변동 폭
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
25.68 | 1.48B | 308.05M | -95.57M | -58.34M | -1.72 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-06 | 개시 | Robert W. Baird | Neutral |
| 2026-02-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2026-02-26 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Alaleh Nouri, EVP at Procept Biorobotics, sells $139k in PRCT stock - Investing.com
PROCEPT BioRobotics (NASDAQ:PRCT) EVP Kevin Waters Sells 706 Shares - MarketBeat
PROCEPT BioRobotics (NASDAQ: PRCT) EVP completes 5,363-share planned sale - Stock Titan
Alalah Nouri (NASDAQ: PRCT) files Form 144 to sell vested RSUs - Stock Titan
PROCEPT BioRobotics (PRCT) CLO sells 304 shares to cover RSU taxes - Stock Titan
PROCEPT (NASDAQ: PRCT) CFO sells 706 shares for tax withholding - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PROCEPT BioRobotics Corporation (PRCT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating PROCEPT BioRobotics Corporation (PRCT) And Encourages Investors to Connect - ACCESS Newswire
PRCT (NASDAQ) insider sale of 6,892 shares; 304 restricted shares vested - Stock Titan
Restricted stock vesting notice at PRCT (NASDAQ: PRCT) with prior insider sale - Stock Titan
Why PROCEPT BioRobotics (PRCT) Is Up 10.8% After Expanding Its AI-Enabled HYDROS System Internationally - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Encourages PROCEPT BioRobotics Corporation (PRCT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
PROCEPT BioRobotics launches HYDROS system in UK By Investing.com - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Encourages PROCEPT BioRobotics Corporation (PRCT) Investors to Inquire about Securities Investigation - ACCESS Newswire
ArrowMark Colorado Holdings LLC Raises Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Assessing PROCEPT BioRobotics (PRCT) Valuation After HYDROS Robotic System Expansion News - simplywall.st
Thematics Asset Management Raises Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Prosight Management LP Takes $2.75 Million Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corp (PRCT) Trading 4.31% Higher on Mar 13 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Investors to Reach Out - ACCESS Newswire
2026-03-13 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Investors to Reach Out | NDAQ:PRCT | Press Release - Stockhouse
Mackenzie Financial Corp Raises Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 65.40% - GuruFocus
Insider Selling: PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells 3,243 Shares of Stock - MarketBeat
PROCEPT BioRobotics (PRCT) EVP sells 3,243 shares under 10b5-1 plan - Stock Titan
PROCEPT BioRobotics launches HYDROS system in UK - Investing.com Australia
Procept BioRobotics announces international Hydros robot launch - MassDevice
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Procept BioRobotics announce international launch of HYDROS Robotic - TipRanks
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy - Koreabizwire
PROCEPT BioRobotics Overcomes S-Curve Challenge as HYDROS Seeks Rapid Expansion of BPH Treatments - Bitget
PROCEPT BioRobotics Announces International Launch of the HYDROS Robotic System, Expanding Global Access to AI-Enabled Aquablation Therapy - Bitget
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.2%Time to Buy? - MarketBeat
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES - marketscreener.com
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - ChartMill
Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - FinancialContent
[144] PROCEPT BioRobotics Corp SEC Filing - Stock Titan
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Benzinga
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up on Insider Buying Activity - MarketBeat
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)? - simplywall.st
Procept Biorobotics director Desai buys PRCT shares worth $10.4m - Investing.com
Major Insider Shake-Up at PROCEPT BioRobotics as Top Executives Trade Shares - TipRanks
Procept Biorobotics director Desai buys PRCT shares worth $10.4m By Investing.com - Investing.com Nigeria
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
PROCEPT BioRobotics (NASDAQ:PRCT) Director Antal Rohit Desai Purchases 167,246 Shares - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Director Buys $3,781,878.03 in Stock - MarketBeat
Insider Buying: PROCEPT BioRobotics (NASDAQ:PRCT) Director Acquires 98,699 Shares of Stock - MarketBeat
Kevin Waters Sells 6,721 Shares of PROCEPT BioRobotics (NASDAQ:PRCT) Stock - MarketBeat
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):